pH regulates potassium conductance and drives a constitutive proton current in human TMEM175
- PMID: 35333573
- PMCID: PMC8956256
- DOI: 10.1126/sciadv.abm1568
pH regulates potassium conductance and drives a constitutive proton current in human TMEM175
Abstract
Human TMEM175, a noncanonical potassium (K+) channel in endolysosomes, contributes to their pH stability and is implicated in the pathogenesis of Parkinson's disease (PD). Structurally, the TMEM175 family exhibits an architecture distinct from canonical potassium channels, as it lacks the typical TVGYG selectivity filter. Here, we show that human TMEM175 not only exhibits pH-dependent structural changes that reduce K+ permeation at acidic pH but also displays proton permeation. TMEM175 constitutively conducts K+ at pH 7.4 but displays reduced K+ permeation at lower pH. In contrast, proton current through TMEM175 increases with decreasing pH because of the increased proton gradient. Molecular dynamics simulation, structure-based mutagenesis, and electrophysiological analysis suggest that K+ ions and protons share the same permeation pathway. The M393T variant of human TMEM175 associated with PD shows reduced function in both K+ and proton permeation. Together, our structural and electrophysiological analysis reveals a mechanism of TMEM175 regulation by pH.
Figures
References
-
- Lawrence R. E., Zoncu R., The lysosome as a cellular centre for signalling, metabolism and quality control. Nat. Cell Biol. 21, 133–142 (2019). - PubMed
-
- Cang C., Aranda K., Seo Y. J., Gasnier B., Ren D., TMEM175 is an organelle K+ channel regulating lysosomal function. Cell 162, 1101–1112 (2015). - PubMed
-
- Nalls M. A., Pankratz N., Lill C. M., Do C. B., Hernandez D. G., Saad M., De Stefano A. L., Kara E., Bras J., Sharma M., Schulte C., Keller M. F., Arepalli S., Letson C., Edsall C., Stefansson H., Liu X., Pliner H., Lee J. H., Cheng R.; International Parkinson’s Disease Genomics Consortium (IPDGC); Parkinson’s Study Group (PSG) Parkinson’s Research: The Organized GENetics Initiative (PROGENI); 23andMe; GenePD; NeuroGenetics Research Consortium (NGRC); Hussman Institute of Human Genomics (HIHG); The Ashkenazi Jewish Dataset Investigator; Cohorts for Health and Aging Research in Genetic Epidemiology (CHARGE); North American Brain Expression Consortium (NABEC); United Kingdom Brain Expression Consortium (UKBEC); Greek Parkinson’s Disease Consortium; Alzheimer Genetic Analysis Group, Ikram M. A., Ioannidis J. P. A., Hadjigeorgiou G. M., Bis J. C., Martinez M., Perlmutter J. S., Goate A., Marder K., Fiske B., Sutherland M., Xiromerisiou G., Myers R. H., Clark L. N., Stefansson K., Hardy J. A., Heutink P., Chen H., Wood N. W., Houlden H., Payami H., Brice A., Scott W. K., Gasser T., Bertram L., Eriksson N., Foroud T., Singleton A. B., Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease. Nat. Genet. 46, 989–993 (2014). - PMC - PubMed
-
- Jinn S., Drolet R. E., Cramer P. E., Wong A. H. K., Toolan D. M., Gretzula C. A., Voleti B., Vassileva G., Disa J., Tadin-Strapps M., Stone D. J., TMEM175 deficiency impairs lysosomal and mitochondrial function and increases α-synuclein aggregation. Proc. Natl. Acad. Sci. U.S.A. 114, 2389–2394 (2017). - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
